NCT07516366 2026-05-15Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT TrialNational Cancer Institute (NCI)Phase 2 Not yet recruiting16 enrolled